The procoagulant effect of thrombin on fibrin(ogen)-bound platelets

Haemostasis

Volumn 28, Issue 6, 1998, Pages 289-300

  Sanders, Marijke W ^a   Nieuwenhuys, Cécile M A ^a   Feijge, Marion A H ^a   Rook, Martin ^b   Béguin, Suzette ^a   Heemskerk, Johan W M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Fibrin; Fibrinogen; Platelets; Procoagulant activity; Thrombin

Indexed keywords

ADRENALIN; ARGINYLGLYCYLASPARTIC ACID; BLOOD CLOTTING FACTOR 10A; CALCIUM CHLORIDE; CALCIUM ION; FIBRIN; FIBRINOGEN; INTEGRIN RECEPTOR; PHOSPHATIDYLSERINE; PROCOAGULANT; THROMBIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0032321942     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022445     Document Type: Article

References (48)

1. Zwaal RFA, Comfurius P, Bevers EM: Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. Biochim Biophys Acta 1992;1180:1-8.
2. Hemker HC: Thrombin generation, an essential step in haemostasis and thrombosis; in Bloom AL, Forbes ED, Thomas DP, Tuddenham EGD (eds): Haemostasis and Thrombosis, ed 3. London, Churchill Livingstone, 1993, pp 477-490.
3. Béguin S, Kumar R: Thrombin, fibrin and platelets: A resonance loop in which von Willebrand factor is a necessary link. Thromb Haemost 1997;78:590-594.
4. Walsh PN: Different requirements for intrinsic factor Xa forming activity and platelet factor 3 activity and their relationship to platelet aggregation and secretion. Br J Haematol 1978;40:311-331.
5. Mann KG, Krishnawamy S, Lawson JH: Surface-dependent hemostasis. Semin Hematol 1992;29:213-226.
6. Weiss HJ: Scott syndrome: A disorder of platelet coagulant activity. Semin Hematol 1994;31:312-319.
7. Toti F, Satta N, Fressinaud E, Meyer D, Freyssinet JM: Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder. Blood 1996;87:1409-1415.
8. Weiss HJ, Lages B: Platelet prothrombinase activity and intracellular calcium responses in patients with storage pool deficiency, glycoprotein IIb-IIIa deficiency, or impaired platelet coagulant activity: A comparison with Scott syndrome. Blood 1997;89:1599-1611.
9. Bevers EM, Comfurius P, van Rijn JLML, Hemker HC, Zwaal RFA: Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets. Eur J Biochem 1982;122:429-436.
10. Rosing J, van Rijn JLML, Bevers EM, van Dieijen G, Comfurius P, Zwaal RFA: The role of activated human platelets in prothrombin and factor X activation. Blood 1985;65:319-332.
11. Sims PJ, Wiedmer T, Esmon CT, Weiss HJ, Shattil SJ: Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. J Biol Chem 1989;264:17049-17057.
12. Williamson P, Bevers EM, Smeets EF, Comfurius P, Schlegel RA, Zwaal RFA: Continuous analysis of the mechanism of activated transbilayer lipid movement in platelets. Biochemistry 1995;34:10448-10455.
13. 2+-dependent transbilayer movement of phospholipid. J Biol Chem 1996;71:17205-17210.
14. 2+ signaling. Eur J Biochem 1997;249:547-555.
15. Jamieson GA: Pathophysiology of platelet thrombin receptors. Thromb Haemost 1997;78:242-246.
16. Xu WF, Andersen H, Whitmore TE, Presnell SR, Yee DP, Ching A, Gilbert T, Davie EW, Foster DC: Cloning and characterization of human protease-activated receptor 4. Proc Natl Acad Sci USA 1998;95:6642-6646.
17. Tans G, Rosing J, Thomassen MCLGD, Heeb MJ, Zwaal RFA, Griffin JH: Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood 1991;77:2641-2648.
18. Goodwin CA, Wheeler-Jones CPD, Kakkar VV, Deadman JJ, Authi KS, Scully MF: Thrombin receptor activating peptide does not stimulate platelet procoagulant activity. Biochem Biophys Res Commun 1994;202:321-327.
19. Pasquet JM, Dachary-Prigent J, Nurden AT: Calcium influx is a determining factor of calpain activation and microparticle formation in platelets. Eur J Biochem 1996;239:647-654.
20. Smeets EF, Heemskerk JWM, Comfurius P, Bevers EM, Zwaal RFA: Thapsigargin amplifies the platelet procoagulant response caused by thrombin. Thromb Haemost 1993;70:1024-1029.
21. 2+-ATPase inhibitors. Biochemistry 1995;34:11625-11634.
22. Pasquet JM, Dachary-Prigent J, Nurden AT: Microvesicle release is associated with extensive protein tyrosine phosphorylation in platelets stimulated by A23187 or a mixture of thrombin and collagen. Biochem J 1998;333:591-599.
23. 2+ responses. Blood 1997;90:2615-2625.
24. Bennett JS, Vilaire G, Cines DB: Identification of the fibrinogen receptor on human platelets by photoaffinity labeling. J Biol Chem 1982;257:8049-8054.
25. Gogstad GO, Brosstad F, Krutnes M, Hagen I, Solum NO: Fibrinogen-binding properties of the human platelet glycoprotein IIb-IIIa complex: A study using cross-radioimmunoelectrophoresis. Blood 1982;60:663-671.
26. Nachman RL, Leung LLK: Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen. J Clin Invest 1982;69:263-269.
27. Shattil SJ, Kashiwagi H, Pampori N: Integrin signaling: The platelet paradigm. Blood 1998;91:2645-2657.
28. Kumar R, Béguin S, Hemker HC: The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity. Thromb Haemost 1995;74:962-968.
29. Reverter JC, Béguin S, Kessels H, Kumar R, Hemker HC, Coller BS: Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effects of c7E3 Fab treatment on acute thrombosis and 'clinical restenosis'. J Clin Invest 1996;98:863-874.
30. Heemskerk JWM, Hoyland J, Mason WT, Sage SO: Spiking in cytosolic calcium concentration in single fibrinogen-bound fura-2-loaded human platelets. Biochem J 1992;283:379-383.
31. Müller-Bergbaus G, Roka L, Lasch HG: Induction of glomerular microclot formation by fibrin monomer infusion. Thromb Diath Haemorrh 1973;29:375-383.
32. 2+ indicators with greatly improved fluorescent properties. J Biol Chem 1985;260:3440-3450.
33. Plow EF, Marguerie GA: Induction of fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP. J Biol Chem 1980;255:10971-10977.
34. Siess W: Molecular mechanisms of platelet activation. Physiol Rev 1989;69:58-178.
35. Hantgan RR: Localisation of the domains of fibrin involved in binding to platelets. Biochim Biophys Acta 1988;968:36-44.
36. Jen CJ, Chen HI, Lai KC, Usami S: Changes in cytosolic calcium concentrations and cell morphology in single platelets adhering to fibrinogen-coated surface under flow. Blood 1996;87:3775-3782.
37. 2+-ATPase in calcium response of single fibrinogen-bound platelets. J Biol Chem 1993;268:356-363.
38. Jen CJ, Lin JS: Direct observation of platelet adhesion to fibrinogen- and fibrin-coated surfaces. Am J Physiol 1991;261:H1457-H1463.
39. Jirousková M, Dyr JE, Suttnar J, Holada K, Trnková B: Platelet adhesion to fibrinogen, fibrin monomer, and fibrin protofibrils in flowing blood; the effect of fibrinogen immobilization and fibrin formation. Thromb Haemost 1997;78:1125-1131.
40. Keularts IMLW, Béguin S, de Zwaan C, Hemker HC: Treatment with a GPIIb/IIIa antagonist inhibits thrombin generation in platelet-rich plasma from patients. Thromb Haemost 1998;80:370-371.
41. FAK in platelets. J Cell Biol 1992;119:905-912.
42. 3. EMBO J 1997;16:6414-6425.
43. 3 through cytoskeletal reorganization and tyrosine phosphorylation in human platelets. J Biol Chem 1995:270:11927-11934.
44. Laffargue M, Monnerau L, Tuech J, Ragab A, Ragab-Thomas J, Payrastre B, Raynal P, Chap H: Integrin-dependent tyrosine phosphorylation and cytoskeletal translocation of Tec in thrombin-activated platelets. Biochem Biophys Res Commun 1997;238:247.
45. Guinebault C, Payrastre B, Racaud-Sultan C, Mazarguil H, Breton M, Mauco G, Plantavid M, Chap H: Integrin-dependent translocation pf phophoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85α with actin filaments and focal adhesion kinase. J Cell Biol 1995;129:831-842.
46. 3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin clots. J Biol Chem 1997;272:1694-1702.
47. 3 binds prothrombin and influences its activation. J Biol Chem 1997;272:27183-27188.
48. Bänninger H, Lämmle B, Furlan M: Binding of α-thrombin to fibrin depends on the quality of the fibrin network. Biochem J 1994;298:157-163.